Navigation Links
Study finds Babies In America Getting Fatter

A new study finds a sharp increase in the number of fat babies; the trend that the researchers feel could have a worrisome implication for the nation’s obesity epidemic//.

Researchers from the Harvard Medical School, who had published their findings of the study in the July issue of Obesity, have shown a 73.5% increase in fat babies over a period of 22-year. Researchers have said that infants now are 59% more likely to be overweight than what they were two decades ago.

Dr. Matthew Gillman, senior author and associate professor of ambulatory care and prevention at Harvard, said, “Even our very youngest children are gaining excess weight, not just adults and adolescents.” Explaining that there were several factors that probably play a key role, he said that right now there are more babies who are large for their gestational age at birth than a quarter-century ago, and this was mainly because the mothers to be were entering pregnancy overweight and subsequently developing gestational diabetes when they are pregnant. What these numbers and study suggests, Dr Gillman said was that, “Our obesity prevention efforts need to start at the earliest stages of human development.”

Researchers explained that they had collected data from visiting more than 120,000 children under the age of six between the years 1980 and 2001. They reported that all the children were from Massachusetts and had enrolled in a health maintenance organization, which provided the medical records that contained the necessary demographic and growth information.

They stated that they were shocked at the results of the study for the youngest age group, which were the infants from birth to six months of age. The researchers found that as they were continuing with the study they found that the number of overweight infants increased by 74%. They also found that the infants also experienced a 59% leap in the risk of becoming overweight, which was the biggest increa
'"/>




Page: 1 2

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...rom a serious kidney ailment died Saturday after j...here//, apparently because he could not afford the...dow of the nephrology ward of the Sanjay Gandhi Po...ces, where he was being treated, hospital sources ...
...ug has been for the first time given the green sig... emotional disturbances// in children and teenager...ug Administration. An antipsychotic drug generally...Risperidone will thus become the first one in its ...
...on form of adult leukemia will require blocking mu... researchers at The University of Texas M. D. Ande... the journal Blood. The research team examined blo...ts with acute myelogenous leukemia (AML) and then ...
...or logical applications apparently also works very...ogy Professor Randall O'Reilly of the University//...much light in the recesses of research trying to f...elligently. While reviewing computer models of th...
Other Medicine News:Health News:Three Molecular Triggers Threaten Leukemia Patients 2Health News:Three Molecular Triggers Threaten Leukemia Patients 3
(Date:10/7/2008)...ented Immunologic Changes Induced by ...nal Data Indicates Potential in Treating Inflammat...ire/ -- Alba Therapeutics Corporation,presented re...merican,College of Gastroenterology (ACG) 2008 Ann...004, the first Phase IIa trial conducted in celiac...
(Date:10/7/2008)... Annual Scientific Meeting -, ORLANDO, Fla., Oct....als, Inc. (formerly Microbia, Inc.) and Forest Lab...presentation of results from a Phase,2b study asse...ients with,irritable bowel syndrome with constipat...nce- daily oral dosing of linaclotide, across a ra...
(Date:10/7/2008)...acebo-Controlled Phase II Study Shows Sta... MOUNTAIN VIEW, California, October 7 /PRNewswire...ature Phase II data from the,therapeutic prostate ...n,obtained as part of the recently entered partner...he US., The results from the Phase II prospective...
(Date:10/7/2008)...Newswire-FirstCall/ --, - 125 Patient, Prospectiv...ws Statistically Significant Improved Overall Surv...e phase II data from the,therapeutic prostate canc...tained as part of the recently entered partnership...S., The results from the Phase II prospective ran...
Breaking Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 5Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial 3B Reports Third Quarter 2007 Financial Results 664 1Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial 3B Reports Third Quarter 2007 Financial Results 664 2Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial 3B Reports Third Quarter 2007 Financial Results 664 3Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial 3B Reports Third Quarter 2007 Financial Results 664 4Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial 3B Reports Third Quarter 2007 Financial Results 664 5Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial 3B Reports Third Quarter 2007 Financial Results 664 6Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial 3B Reports Third Quarter 2007 Financial Results 664 7Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial 3B Reports Third Quarter 2007 Financial Results 664 8Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial 3B Reports Third Quarter 2007 Financial Results 664 9Meningitis Shot Available Effective Year Round 4629 1Meningitis Shot Available Effective Year Round 4629 2Meningitis Shot Available Effective Year Round 4629 3Staying sharp in San Diego 4626 1Gentiva 28R 29 Health Services to Present November 7 at CIBC Healthcare Conference in New York 4623 1Gentiva 28R 29 Health Services to Present November 7 at CIBC Healthcare Conference in New York 4623 2Gentiva 28R 29 Health Services to Present November 7 at CIBC Healthcare Conference in New York 4623 3
...7 /PRNewswire-FirstCall/ --,Pharmacyclics, Inc. an... novel histone deacetylase (HDAC) inhibitor and,Br...esentations,will take place at the American Associ...ng being held April 14-18, 2007, at the Los,Angele...e presentations are as follows:, Sunday, Apri...
...t EASL Conference in Barcelona,Spain, VANCOUVER a...Call/ - MIGENIX Inc. , a clinical-stage developer,... top-line results,confirming the previously announ... evidence of clinical benefit, safety and,tolerabi...osidase,inhibitor, celgosivir (MX-3253), in combin...
Other Medicine Technology:Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 2Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 3Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 4New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 2New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 3New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 4New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 5New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 6New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 7New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 8
Cordis DUCOR Catheters are available in a broad variety of French sizes and configurations. These catheters combine an atraumatic tip with either a braided or non-braided body.
The advanced center-of-the-arc system allows an infinite choice of trajectories. The system's lightweight durable frame provides accuracy, simplicity, patient mobility and accessibility.
The CRW system epitomizes simplicity, quality assurance, and versatility.
Used for complex diagnostic and interventional procedures.
Medicine Products: